Sarda Proteins Ltd - 519242 - Revised Outcome Of Board Meeting Held On Saturday, July 4, 2026
Sarda Proteins board has approved a change in the company name, which will be subject to approval from the Central Registration Centre, Ministry of Corporate Affairs. This change will also involve necessary alterations to the Memorandum of Association and Articles of Association.
Jul 22 2026 18:50:12
Sarda Proteins Ltd - 519242 - Intimation Of Addendum To The Notice Of The Extraordinary General Meeting (EGM) To Be Held On 30.07.2026
Sarda Proteins will hold an EGM on July 30, 2026, to seek shareholder approval for the appointment of new statutory auditors to fill a casual vacancy and for the regularization of a Woman Independent Director. This implies a previous auditor resignation and strengthens board governance.
Jul 16 2026 17:40:00
Sarda Proteins Ltd - 519242 - Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
Sarda Proteins established a new corporate office in Rajkot, Gujarat, effective July 15, 2026. The company also shifted its registered office to a new address within Alwar, Rajasthan, on the same date.
Jul 15 2026 18:16:40
Sarda Proteins Ltd - 519242 - Board Meeting Outcome for Outcome Of The Board Meeting To Consider Financial Result
Sarda Proteins' board approved Q1 FY27 standalone financial results, with total revenue at ₹18.47 crores and net profit of ₹1.66 crores. This marks a significant turnaround from a loss in Q1 FY26.
Jul 15 2026 17:56:59
Sarda Proteins Ltd - 519242 - Board Meeting Intimation for Consider And Approve The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026.
Sarda Proteins Ltd. announced a board meeting on July 15, 2026, to consider and approve its Q1 FY27 financial results. This meeting is a routine update for upcoming earnings.
Jul 09 2026 16:40:11
Sarda Proteins Ltd - 519242 - Extra Ordinary General Meeting Of The Members SARDA PROTEINS LIMITED Will Be Held On THURSDAY, 30 JULY 2026 Through Audio Visual Means At 11.00 A.M.
Sarda Proteins Ltd. will hold an EGM on July 30, 2026, to approve major strategic initiatives. These include increasing the authorized share capital to Rs.100 crore, expanding the company's main business object clause, regularizing key director appointments, and changing the company's name to Sarda Enterprises Ltd. to reflect its diversified business profile and future growth plans.
Jul 06 2026 18:32:19
Sarda Proteins Ltd - 519242 - Announcement under Regulation 30 (LODR)-Resignation of Managing Director
Sarda Proteins' Managing Director, Chirag Shantilal Thummar, has resigned due to personal reasons, effective July 4, 2026. The company has appointed Shirish Dhirajlal Savaliya as the new MD for a five-year term, subject to shareholder approval.
Jul 04 2026 18:06:36
Sarda Proteins Ltd - 519242 - Announcement under Regulation 30 (LODR)-Resignation of Director
Sarda Proteins announced the resignation of Managing Director Chirag Shantilal Thumar, along with three other directors (Bipinkumar Savalia, Khilan Savaliya, and Independent Director Chintan Bhatt), all effective July 4, 2026. The directors cited personal reasons and pre-occupations.
Jul 04 2026 18:05:13
Sarda Proteins Ltd - 519242 - Announcement under Regulation 30 (LODR)-Change in Management
Sarda Proteins' board approved significant leadership changes, including the resignations of its MD and three directors. The board also appointed Shirish Savaliya as the new MD, Drashti Delvadiya as CFO, and redesignated Yagnik Satasiya from CFO to Additional Director.
Jul 04 2026 18:03:58
Sarda Proteins Ltd - 519242 - Board Meeting Outcome for Outcome Of Board Meeting
Sarda Proteins' Board approved a substantial increase in authorized equity share capital from ₹13 crore to ₹100 crore. The board also appointed Shirish Savaliya as Managing Director and Drashti Delvadiya as Chief Financial Officer, following the resignation of Chirag Thumar as MD and three other directors.
Jul 04 2026 17:47:09
Read More